Logo
x

Search

Subscribe Now

bms

PharmaShots Weekly Snapshots (September 02 – September 06, 2024)

PharmaShots Weekly Snapshots (September 02 – September 06, 2024)

  • September 6, 2024
BMS Reports Results from P-III (MAVA-LTE) Trial of Camzyos to Treat Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

BMS Reports Results from P-III (MAVA-LTE) Trial of Camzyos to Treat Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

  • September 2, 2024
BMS Reports the EMA’s Validation of Application for Opdivo Plus Yervoy to Treat Hepatocellular Carcinoma

BMS Reports the EMA’s Validation of Application for Opdivo Plus Yervoy to Treat Hepatocellular Carcinoma

  • July 19, 2024
BMS’ Krazati Receives the US FDA’s Accelerated Approval to Treat Locally Advanced or Metastatic Colorectal Cancer (mCRC)

BMS’ Krazati Receives the US FDA’s Accelerated Approval to Treat Locally Advanced or Metastatic Colorectal Cancer (mCRC)

  • June 25, 2024
BMS Reports the EMA’s Validation of the Application for Subcutaneous Opdivo

BMS Reports the EMA’s Validation of the Application for Subcutaneous Opdivo

  • June 21, 2024
BMS Reports the US FDA’s Accelerated Approval of Augtyro to Treat Locally Advanced or Metastatic Solid Tumors

BMS Reports the US FDA’s Accelerated Approval of Augtyro to Treat Locally Advanced or Metastatic Solid Tumors

  • June 14, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.